ROI Past 4 Years | ROI This Year | Close Price | Up & Down 1 | Fair Price 1 | Target Price After 1 Year | ROI 1 | Growth Rate This Year | Up & Down 5 | Fair Price 5 | Target Price After 5 Year | ROI 5 | CGAR Growth Rate in 5 Years | PE | Avg PE |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
32.78% | -13.95% | 27.63 (04-25) | 6.0% | 29.4 | 32.05 | 16.0% | 19.38~23.69% | 23.0% | 35.72 | 54.96 | 14.74% | 17.73~21.67% | 28.68 | 43.8 |
- Fair Price 1: Calculating by "Target Price After 1 Year
- Up & Down 1: The gap between "Price 5" and "Close Price"
- Fair Price 5: Calculating by "Target Price After 5 Year
- Up & Down 5: The gap between "Price 5" and "Close Price"
- ROI1: Possible ROI after 1 year
- ROI 5: Possible 5 year IRR
- Fair price is for reference only, please do your down research
PE Ratio | Stock Price(Optimistic Growth Rate) | Gap to Close Price(%) | Stock Price(Pessimistic Growth Rate) | Gap to Close Price(%) | |
PE Ratio of Highest Price | 55.04 | 134.27 | 385.96% | 133.55 | 383.35% |
PE Ratio of Lowest Price | 32.56 | 79.44 | 187.51% | 79.02 | 185.99% |
- PE ratio of highest price is the median of historical PE ratios of highest prices; PE ratio of lowest price is the median of historical PE ratios of lowest prices
- Fair price is for reference only, please do your down research
Year | Highest Price | Lowest Price | EPS | Highest PE Ratio | Lowest PE Ratio |
---|---|---|---|---|---|
2023 | 43.66 | 34.65 | N/A | N/A | N/A |
2022 | 47.5 | 26.19 | 4.55 | 79.73 | 43.95 |
2021 | 49.07 | 30.1 | 4.55 | 82.4 | 50.53 |
2020 | 41.5 | 16.24 | 7.22 | 43.95 | 17.2 |
2019 | 24.5 | 14.48 | 3.4 | 55.04 | 32.56 |
2018 | 103.19 | 12.1 | 2.37 | 332.44 | 38.98 |
- This year's EPS is apredicted value
Weekly Resistance and Support: 30.08, 26.32
Monthly Resistance and Support: 34.65, 26.19
Daily Resistance and Support: 28.29, 27.51
Weekly stoch: k - 23.56, d - 37.06
Monthly stoch: k - 7.86, d - 12.58
Daily stoch: k - 4.58, d - 11.81
Weekly RSI: 33.15
Monthly RSI: 37.85
Daily RSI: 33.78
Close Price: 27.63
SMA3: 28.22↘ SMA5: 28.47↘ SMA10: 28.74↘ SMA17: 29.15↘ SMA20: 29.29↘ SMA25: 29.47↘ SMA45: 29.5↘
SMA60: 29.11→ SMA100: 29.79↘ SMA104: 29.83↘ SMA120: 29.99↘ SMA200: 32.49↘ SMA240: 33.62↘ SMA269: 34.34↘
HIgh (52W): 2939.0 (-99.06%, 2023-05-23)
Low (52W): 1825.0 (-98.49%, 2024-02-13)
PS Ratio(TTM): 8.0237
Market Cap (100Million): 1321.82
beta: 0.436912
EPS Growth Rate (3Y): -2.94%
Revenue Growth Rate (3Y): 17.67%
EPS Growth Rate (5Y): 22.71%
Revenue Growth Rate (5Y): 40.35%
Gross Margin(TTM): 97.31%
Operating Margin(TTM): 35.7%
Net Margin(TTM): 19.79%
Pretax Margin(TTM): 13.68%
ROE(TTM): 48.39%
Gross Margin (5Y): 75.26%
Operating Margin (5Y): 44.33%
Pretax Margin (5Y): 47.93%
Net Margin (5Y): 37.21%
ROA (5Y): 9.29%
ROE (5Y): 17.72%
Argenx stockgmab dkGMAB stock forecastgenmab employee benefitsgmab acronymGenmab stockgmab stock forecastNovo Nordisk stockGSK stockNTLA stockCyberark stockAlnylam stockgenmab dkk pricePaccar stocknavo stocklnmd stockGMAB meaningCprt stockgmab technical analysisgmab stock dividendWWE stocknivo stockVrtx stockgmab target priceNovo b stock priceCPRT stocknovi stockFlex stocknovonor stocktrikafta stockINCY stockBmrn stockAscendis stockMNST stockLegn stockNovov b stock priceLEGN stockNovov B stock pricegenmab investor relationsNordic stockgmab financial analysisSeagen stockØrsted stockgemoab stockBntx stockTs stockBNTX stockColoplast stockgenmab pipelinesaxenda stockhrmy stockVestis stockZEAL stockCarlsberg StockAmph stockROCKWOOL stockVerisk stockIBRX stockgenmab newsNasdaq GMAByahoo finance genmabHrmy stockVRTX stockRGEN stock